Novaken Pharma, Yifly Technology Among Firms Receiving CSRC Acceptance for Hong Kong IPO Filings

Intelligent Finance APP learned on January 30 that the China Securities Regulatory Commission (CSRC) released the "Filing Status Table for Domestic Enterprises' Overseas Issuance of Securities and Listing (Initial Public Offering and Full Circulation) (As of January 30, 2026)." Among them, Novaken, Wingpharm Technology, DaoYuan Technology, Carlink World, WeMed, Jingwang Electronics, Juncell Therapeutics, and Mainline Technology's proposed Hong Kong IPO materials were received by the CSRC; Laoxiangji.(Indirect Overseas Listing) Proposed Hong Kong IPOThe filing status is open for public comments;CoreMed SemiconductorThe status of the proposed Hong Kong IPO filing is "Supplemental Materials Required."